FDA Commissioner Dr. Marty Makary said Thursday that the United States needs to transform its health care approach from treating disease to preventing it, as the Trump administration unveiled a ...

For the nearly 30 percent of major depressive disorder patients who are resistant to treatment, ketamine provides some amount of normalcy, but it requires frequent treatment and can have side effects.

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally ...

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally different way of treating depression symptoms in adults with major ...

Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in ...

Researchers have developed a machine learning–based model that can stratify the risk for postpartum depression directly after delivery.

Nevada Mental Health, one of the state’s largest psychiatric practices, just started offering SPRAVATO®, a nasal mist ...

Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.

An independent analysis found virtual mental health solutions for depression and anxiety effectively treat the conditions, ...

Sponsor: Optimum TMS Treating depression is rarely one-size-fits-all—and sometimes, even proven methods stop being effective ...

An estimated 21 million adults in the U.S. live with depression, and over half experience treatment-resistant depression.

Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...